Finasteride supported as chemoprevention in PCa.

The article discusses the result of an initiative of leading European urologists to review the findings from the Prostate Cancer Prevention Trial. After the review, the urologists have reached consensus supporting the use of finasteride (Proscar) as a chemopreventive agent for the disease. Per-Anders Abrahamsson of the Malmo University in Sweden states that, after reviewing the data, European urologists community agreed to the use of finasteride for those concerned about developing cancer.